Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

The skin microbiome plays a key role in treating atopic dermatitis.

New technologies replicate human skin for testing without animals.

Alopecia areata involves specific immune cells, offering potential treatment targets.

The enzymes Tet2 and Tet3 are important for skin cell development and hair growth.

SOD1 and KL are promising targets for new hair loss treatments.

TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.

New nanocarriers improve drug delivery for disease treatment.

Organoids and hair-on-chip technologies show promise for hair regeneration but face clinical challenges.

Hemp shows promise for skincare and hair care due to its therapeutic properties, but standardization and clinical evidence are needed.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Curcuma longa and Dalbergia sissoo may work well together to treat inflammation, stress, and cancer.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Cedrol may help treat inflammatory bowel disease by improving gut health and function.

Repurposing existing drugs can quickly and cheaply find new treatments for diseases.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

Cosmeceuticals may have potential but their effectiveness and market success are still uncertain.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Regulatory T cells help control the immune system and could lead to new treatments for diseases.

Human amniotic stem cells can safely treat psoriasis-like skin in mice.

BMS-470539 reduces skin fibrosis and inflammation.

Advancements in medical physics and laser technology are improving healthcare but access remains unequal globally.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Stem cell therapy shows promise but needs better safety and quality standards.